Lumakras OverviewSotorasib, sold under the brand name Lumakras is an anti-cancer medication used to treat non-small-cell lung cancer (NSCLC). It targets a specific mutation, G12C, in the protein KRAS which is responsible for various forms of cancer. The most common side effects include diarrhea, musculoskeletal pain, nausea, fatigue, liver damage and cough. Sotorasib is an inhibitor of the RAS GTP...
Read more Lumakras Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sotorasib
Recent Lumakras Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 120mg
NDC Database Records for Lumakras: (1 result)Sorted by National Drug Code
- 55513-488 Lumakras 120 mg Oral Tablet, Coated by Amgen Inc